![HealthBiz with David E. Williams artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts124/v4/1e/17/d5/1e17d53b-e8a2-b0a8-e64b-07535e7da520/mza_5223959774649917786.jpg/100x100bb.jpg)
CNS drug development roundtable with Annovis and Clene
HealthBiz with David E. Williams
English - January 20, 2022 13:00 - 22 minutes - 15.5 MB - ★★★★★ - 42 ratingsManagement Business healthcare business health care healthcare policy entrepreneurship ceo interview Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Regenerative medicine roundtable
Next Episode: Interview with Shoreline CEO Kleanthis Xanthopoulos
Alzheimer’s, Parkinson's, ALS, MS --these are all serious or fatal neurodegenerative diseases that lack effective treatments. Thankfully, innovative companies are developing promising, novel therapies in the field.
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group. Produced by Dafna Williams.